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Introduction
Familial Mediterranean Fever (FMF) is an ethnic disease
for Armenians. Recurrent attacks of fever with tonsillitis
are also clinical symptom of FMF, especially in early child-
hood. They are also characteristic of the PFAPA syndrome
(periodic fever, aphthous stomatitis, pharyngitis, adenopa-
thy), which can be confused with FMF.
Objective
To investigate the peculiarities of the coexistence of
PFAPA syndrome and FMF in Armenian children.
Methods
28 children with recurrent episodes of fever and tonsillitis
was observed at the National Pediatric Centre for FMF (19
boys, 9 girls, aged from 1 to 8 year). The diagnosis of FMF
was confirmed by Tel-Hashomer criteria and molecular
genetic detection of MEFV mutations. PFAPA syndrome
was diagnosed based on recognized clinical criteria and
excluding other causes of tonsillitis.
Results
Coexistence of FMF and PFAPA was in 10 out of
28 patients (36%). They had earlier FMF onset (mean age
of 1y. 3 mo.), frequent febrile attacks of abdominal pain
and/or pleuritis, pericarditis (7 out of 10 patients), aphthous
stomatitis (6 patients), tonsillitis with cervical lymphadenitis
(9 children), as well as marked increase of acute inflamma-
tory markers. An average age of PFAPA manifestation was
2 years 2 mo. MEFV gene M694V mutation was found in
8 patients out of 10 with the following distribution of geno-
types:: one homozygous genotype (V726A/V726A), 5 com-
pound heterozygotes: (M694V/V726A (2), M694V/F479L
(2), M694V/E148Q (1), 4 heterozygotes (M694V/N (3 chil-
dren), V726A/N (1).
Isolated PFAPA syndrome was diagnosed in 18 out of 29
children (mean age of onset - 2 years 4 mo.). They had
repeated attacks of fever and tonsillitis, rare - pleuritis or
pericarditis (4 children), occasionally - mild abdominal
pain and a moderately increased acute phase reactants. 13
out of 18 patients were carriers of one mutation, mostly
M694V/N (9 out of 13). The frequency of PFAPA attacks
in both groups of patients was similar (1-2 times a month).
Conclusion
The coexistence of PFAPA syndrome and FMF was
noticed in 36% of investigated children. They were charac-
terized by earlier FMF onset, severe course of disease with
frequent febrile attacks and the prevalence of MEFV com-
pound-heterozygous genotype. In contrast, among patients
with isolated PFAPA syndrome prevailed heterozygous
genotype. M694V mutation was the most frequent.
MEFV mutation genetic screening is recommended
for Armenian children, especially under the age of 5,
with recurrent fever and tonsillitis for early diagnosis of
FMF, differential diagnosis with PFAPA syndrome, treat-
ment and prevention of complications.
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